2002 - 2010 3. Development of adeno-associated Viral vectors
2002 - 2010 2. Study on oncogenicity of human papillomaviruses
2001 - 2010 1. Development of vaccine for human papillomaviruses
2000 - 2010 HPV増殖機構の解析
2000 - 2010 HPV予防ワクチンの開発
全件表示
MISC (117件):
KAWANA K, YASUGI T, KANDA T, KAWANA Y, HIRAI Y, YOSHIKAWA H, TAKETANI Y. Kawana, K., Yasugi, T., Kanda, T., Kawana, Y., Hirai, Y., Yoshikawa, H., Taketani, Y.: Neutralizing antibodies against oncogenic human papillomavirus (HPV) as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia. BBRC. 2002. 296. 1. 102-105
Mori, S., Murakami, M., Takeuchi, T., and Kozuka, T., Kanda, T., : Rescue of AAV by sntibody-Induced Fas-Mediated Apoptosis from Viral DNA Integrated in HeLa Chromosome. Virology, 301:90-98, 2002
Kawana, k., Yasugi, T., Kanda, T., Kawana, Y., Hirai, Y., Yoshikawa, H., Taketani, Y., : Neutralizing Antibodies against Oncogenic Human Papillomavirus (HPV) as a Possible Determinant of the Fate of Low-Grade Cervical Intraepithelial Neoplasia. BBRC, 296:102-105, 2002
Matsumoto, K., Yoshikawa, H., Yasugi, T., Nakagawa, S., Kawana, K., Takeoka, A., Yaegashi, N., Iwasaka, T., Kanazawa, K., Taketani, Y., and Kanda, T., : IgG Anitibodies to Human Papillomavirus 16, 52, 58 and 6 Li-Capsids: a Case-Control Study of Cervic・・・. J. Medical Virology, in Press, 2002